Inflammation-driven conditions such as hepatitis not only foster fibrosis but also contribute to carcinogenic mutations, with LOX sustaining a pro-inflammatory and ECM rigidifying niche, thereby perpetuating an “inflammation-fibrosis-cancer” continuum (105, 106). Here, LOX is linked to cancer.